An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who's been taking Mounjaro (a prescription drug) since November 2025 wrote in asking whether to stay at their current dose or increase it. They started low and moved up to 5 mg in January. They’ve lost about 20 kg (45 pounds) from 103 kg to about 83–84 kg and say their inflammation has improved a lot. Lately the weight loss has slowed, and they’re wondering if upping the dose would help. Mounjaro is the brand name for tirzepatide. In plain terms, it’s a medicine that acts like natural gut hormones that tell your brain you’re full and slow how fast your stomach empties. That reduces appetite and helps people eat less, which leads to weight loss over time. It’s also used to treat type 2 diabetes because it helps control blood sugar. People without diabetes are using it for weight loss and some inflammatory conditions, though those uses depend on a doctor’s judgment. The report here is an individual’s experience—not a clinical trial. They describe clear benefits: notable weight loss (about 20 kg) and much-improved inflammation. But their pace of weight loss has slowed recently, which is common as people get closer to a new stable weight or their body adjusts. This single-person account can’t tell us what will happen for others or whether increasing the dose will work for them. Formal studies show higher doses of tirzepatide can produce bigger average weight loss across groups, but effects and side effects vary between individuals. Why this matters is practical. If someone is losing weight and seeing inflammation improve, that’s a positive clinical outcome worth keeping. Slower weight loss after an initial drop doesn’t necessarily mean the drug has stopped working; it might mean the person’s body is adapting or they’re reaching a healthier set point. Deciding to increase the dose could yield more weight loss for some, but it could also bring more side effects. So the main people who care are the patient and their prescribing clinician—especially because the drug interacts with other health issues, personal goals, and medications. Important caveats: this is a self-report, not medical advice. Mounjaro has side effects like nausea, diarrhea, constipation, stomach discomfort, and in rare cases more serious problems. Dose changes should always be made under a doctor’s supervision. People with certain conditions or taking certain medicines might need extra caution. Also, long-term effects on inflammation or off-label uses aren’t fully settled in all groups. If someone is considering a higher dose, they should discuss it with their clinician, weigh the risks and benefits, and consider monitoring plans. Bottom line: The person’s experience looks positive overall, but whether to increase the dose depends on individual goals, side effects, and a careful discussion with their doctor rather than guessing from one anecdote.
Source: r/Mounjaro